Newsroom

Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference
Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb
Lab-created heart valves can grow with the recipient article published in Science Translational Medicine
Vascudyne is awarded Regenerative Medicine Minnesota grant on transcatheter regenerative tissue pulmonary valve project
Vascudyne’s CSO presents at the Heart Valve Society Meeting on engineered tissue transcatheter valve for pulmonary and tricuspid valve implant
Vascudyne is awarded Regenerative Medicine Minnesota grant on development of regenerative engineered tissue embedded cardiovascular device project
University of Minnesota startup Vascudyne to commercialize biologic engineered tissue with potential to transform medical device technology
New tissue-engineered blood vessel replacements closer to human trials article published in Science Translational Medicine

Proud Member of:

Copyright 2021 | Vascudyne, Inc.